Genetic Technologies Ltd (GENE) — Strategic Asset Allocation Index
Genetic Technologies Ltd (GENE) has a Strategic Asset Allocation Index of 5.4% as of June 2023. Strategic assets (PP&E of $599.18K plus long-term investments of $-) total $599.18K, measured against net assets of $11.16 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See GENE equity financing ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Genetic Technologies Ltd Strategic Asset Allocation Index (2003–2023)
This chart shows how Genetic Technologies Ltd's Strategic Asset Allocation Index has evolved across 21 annual periods from 2003 to 2023. As of June 2023, the index stands at 5.4%, representing strategic assets of $599.18K against net assets of $11.16 Million USD. For live market cap and overall valuation, see GENE stock market capitalisation.
Annual Strategic Asset Allocation Index for Genetic Technologies Ltd (2003–2023)
The table below presents the year-by-year Strategic Asset Allocation Index for Genetic Technologies Ltd from 2003 to 2023, covering 21 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See GENE net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 5.4% | $599.18K | $599.18K | $- | $11.16 Million | ▼ -0.4 pp |
| 2022 | 5.8% | $953.33K | $953.33K | $- | $16.43 Million | ▲ +2.8 pp |
| 2021 | 3.0% | $637.71K | $637.71K | $- | $21.53 Million | ▼ -0.2 pp |
| 2020 | 3.1% | $440.23K | $440.23K | $- | $13.99 Million | ▼ -0.8 pp |
| 2019 | 3.9% | $69.33K | $69.33K | $0.00 | $1.77 Million | ▲ +0.2 pp |
| 2018 | 3.7% | $175.28K | $175.28K | $0.00 | $4.71 Million | ▼ -0.8 pp |
| 2017 | 4.5% | $476.65K | $476.65K | $0.00 | $10.58 Million | ▼ -0.1 pp |
| 2016 | 4.6% | $550.14K | $550.14K | $0.00 | $11.88 Million | ▲ +2.9 pp |
| 2015 | 1.7% | $321.90K | $321.90K | $0.00 | $18.96 Million | ▼ -15.3 pp |
| 2014 | 17.0% | $311.32K | $311.32K | $0.00 | $1.83 Million | ▲ +10.3 pp |
| 2013 | 6.7% | $388.00K | $388.00K | $- | $5.76 Million | ▲ +2.2 pp |
| 2012 | 4.6% | $658.00K | $658.00K | $- | $14.40 Million | ▼ -10.4 pp |
| 2011 | 14.9% | $1.02 Million | $1.02 Million | $- | $6.81 Million | ▼ -14.4 pp |
| 2010 | 29.3% | $1.68 Million | $1.68 Million | $- | $5.72 Million | ▲ +15.4 pp |
| 2009 | 13.9% | $2.42 Million | $2.42 Million | $- | $17.49 Million | ▲ +6.0 pp |
| 2008 | 7.8% | $1.63 Million | $1.63 Million | $- | $20.83 Million | ▼ -1.9 pp |
| 2007 | 9.8% | $1.65 Million | $1.65 Million | $- | $16.90 Million | ▲ +0.6 pp |
| 2006 | 9.2% | $1.68 Million | $1.68 Million | $- | $18.27 Million | ▲ +0.5 pp |
| 2005 | 8.7% | $1.99 Million | $1.99 Million | $- | $22.75 Million | ▲ +1.2 pp |
| 2004 | 7.5% | $1.29 Million | $1.29 Million | $- | $17.07 Million | ▲ +3.9 pp |
| 2003 | 3.7% | $999.00K | $999.00K | $- | $27.28 Million | — |